Oncologists have grown increasingly excited about “antibody drug conjugates,” which allow for the use of more potent chemotherapy agents with fewer side effects.
Oncologists have grown increasingly excited about “antibody drug conjugates,” which allow for the use of more potent chemotherapy agents with fewer side effects.
Leave a reply